Literature DB >> 22854874

[Therapeutic hypothermia in acute brain injury].

B Kallmünzer1, R Kollmar, S Schwab.   

Abstract

Induced therapeutic hypothermia (TH) is defined as a controlled reduction of the core body temperature below the physiological range. While TH is neuroprotective in many different models of brain injury, it is only recommended for patients after cardiopulmonary resuscitation and newborns suffering from perinatal hypoxic-ischemic encephalopathy (HIE). Although a strong association exists between elevated body core temperature (fever) and worsening of outcome, TH has so far not been proven to influence outcome after ischemic stroke, intracerebral hemorrhage or subarachnoidal hemorrhage because of insufficient clinical data. This review summarizes the data on TH for different clinical indications and discusses relevant aspects of its use in neurological intensive care units.

Entities:  

Mesh:

Year:  2012        PMID: 22854874     DOI: 10.1007/s00115-012-3568-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  27 in total

1.  Endovascular cooling for moderate hypothermia in patients with acute stroke: first results of a novel approach.

Authors:  D Georgiadis; S Schwarz; R Kollmar; S Schwab
Journal:  Stroke       Date:  2001-11       Impact factor: 7.914

2.  Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial.

Authors:  Rainer Kollmar; Eric Juettler; Hagen B Huttner; Arnd Dörfler; Dimitre Staykov; Bernd Kallmuenzer; Erich Schmutzhard; Stefan Schwab; Gregor Broessner
Journal:  Int J Stroke       Date:  2012-02       Impact factor: 5.266

Review 3.  Temperature management in stroke - an unsolved, but important topic.

Authors:  Bernd Kallmünzer; Rainer Kollmar
Journal:  Cerebrovasc Dis       Date:  2011-04-12       Impact factor: 2.762

Review 4.  Therapeutic hypothermia and controlled normothermia in the intensive care unit: practical considerations, side effects, and cooling methods.

Authors:  Kees H Polderman; Ingeborg Herold
Journal:  Crit Care Med       Date:  2009-03       Impact factor: 7.598

Review 5.  Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis.

Authors:  H Bart van der Worp; Emily S Sena; Geoffrey A Donnan; David W Howells; Malcolm R Macleod
Journal:  Brain       Date:  2007-05-03       Impact factor: 13.501

6.  Ice-cold saline for the induction of mild hypothermia in patients with acute ischemic stroke: a pilot study.

Authors:  Rainer Kollmar; Peter D Schellinger; Tobias Steigleder; Martin Köhrmann; Stefan Schwab
Journal:  Stroke       Date:  2009-01-29       Impact factor: 7.914

7.  Therapeutic hypothermia in patients with aneurysmal subarachnoid hemorrhage, refractory intracranial hypertension, or cerebral vasospasm.

Authors:  Martin A Seule; Carl Muroi; Susanne Mink; Yasuhiro Yonekawa; Emanuela Keller
Journal:  Neurosurgery       Date:  2009-01       Impact factor: 4.654

8.  Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction.

Authors:  S Schwab; S Schwarz; M Spranger; E Keller; M Bertram; W Hacke
Journal:  Stroke       Date:  1998-12       Impact factor: 7.914

9.  Intravascular Cooling in the Treatment of Stroke (ICTuS): early clinical experience.

Authors:  Patrick D Lyden; Robin L Allgren; Ken Ng; Paul Akins; Brett Meyer; Fahmi Al-Sanani; Helmi Lutsep; John Dobak; Bradley S Matsubara; Justin Zivin
Journal:  J Stroke Cerebrovasc Dis       Date:  2005 May-Jun       Impact factor: 2.136

10.  Mild hypothermia of 34°C reduces side effects of rt-PA treatment after thromboembolic stroke in rats.

Authors:  Bernd Kallmünzer; Stefan Schwab; Rainer Kollmar
Journal:  Exp Transl Stroke Med       Date:  2012-03-07
View more
  1 in total

1.  Hypothermia exerts early neuroprotective effects involving protein conjugation of SUMO‑2/3 in a rat model of middle cerebral artery occlusion.

Authors:  Gang Li; Xiaozhi Liu; Zhiguo Su; Dong Zhang
Journal:  Mol Med Rep       Date:  2017-07-15       Impact factor: 2.952

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.